Maintaining high expression of IFNAR2 and restoring normal levels of type I interferon can effectively inhibit the proliferation of tumor cells, thereby reducing the risk of laryngeal cancer or improving the treatment effect of laryngeal cancer patients during IFN treatment. This evidence concerns the gene IFNAR2 and neoplasm.